ROBERTS BRANDI (Chief Financial Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/5/2026ACC: 0001193125-26-039585
Officer· Chief Financial Officer
Since Feb 2026
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
New position
2/3/2026
0.00→150K
Total
Net shares
+150K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/3/2026 | A · Award | +150K | — | — | New position | 0.00 | 150K |
| Total | +150K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported